John N. Eble

24.6k total citations · 6 hit papers
290 papers, 17.2k citations indexed

About

John N. Eble is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, John N. Eble has authored 290 papers receiving a total of 17.2k indexed citations (citations by other indexed papers that have themselves been cited), including 147 papers in Pulmonary and Respiratory Medicine, 139 papers in Molecular Biology and 90 papers in Surgery. Recurrent topics in John N. Eble's work include Renal cell carcinoma treatment (98 papers), Renal and related cancers (93 papers) and Cancer Genomics and Diagnostics (41 papers). John N. Eble is often cited by papers focused on Renal cell carcinoma treatment (98 papers), Renal and related cancers (93 papers) and Cancer Genomics and Diagnostics (41 papers). John N. Eble collaborates with scholars based in United States, Italy and Spain. John N. Eble's co-authors include Liang Cheng, Brett Delahunt, David J. Grignon, Guido Martignoni, Thomas M. Ulbright, Brett Delahunt, John R. Srigley, Michael O. Koch, Gregory T. MacLennan and Timothy D. Jones and has published in prestigious journals such as Nature, The Lancet and Circulation.

In The Last Decade

John N. Eble

288 papers receiving 16.7k citations

Hit Papers

The Heidelberg classification of renal cell tumours 1997 2026 2006 2016 1997 2004 2013 1997 1997 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John N. Eble United States 69 10.5k 9.4k 4.8k 3.9k 2.8k 290 17.2k
George J. Netto United States 65 7.4k 0.7× 7.5k 0.8× 5.2k 1.1× 3.5k 0.9× 4.6k 1.7× 390 17.6k
David J. Grignon United States 76 14.6k 1.4× 6.0k 0.6× 4.9k 1.0× 3.7k 0.9× 3.5k 1.3× 364 20.8k
Satish K. Tickoo United States 59 7.5k 0.7× 6.6k 0.7× 3.5k 0.7× 3.2k 0.8× 2.3k 0.8× 187 11.9k
Antonio López-Beltrán Spain 63 7.0k 0.7× 5.6k 0.6× 7.7k 1.6× 2.7k 0.7× 3.5k 1.3× 537 16.5k
Mitchell C. Benson United States 52 8.6k 0.8× 3.9k 0.4× 3.1k 0.7× 2.2k 0.6× 2.8k 1.0× 268 13.3k
Christopher J. Logothetis United States 75 9.6k 0.9× 6.9k 0.7× 3.9k 0.8× 3.7k 0.9× 7.9k 2.9× 458 20.8k
Isabell A. Sesterhenn United States 58 5.6k 0.5× 4.2k 0.5× 3.1k 0.7× 2.3k 0.6× 2.3k 0.8× 213 11.2k
Ming Zhou United States 53 7.2k 0.7× 4.5k 0.5× 1.9k 0.4× 2.3k 0.6× 1.7k 0.6× 211 10.3k
Axel S. Merseburger Germany 50 9.6k 0.9× 5.9k 0.6× 4.1k 0.9× 2.6k 0.7× 2.5k 0.9× 421 14.3k
Kurt Miller Germany 59 9.1k 0.9× 4.6k 0.5× 2.1k 0.5× 3.5k 0.9× 2.9k 1.1× 358 14.7k

Countries citing papers authored by John N. Eble

Since Specialization
Citations

This map shows the geographic impact of John N. Eble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John N. Eble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John N. Eble more than expected).

Fields of papers citing papers by John N. Eble

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John N. Eble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John N. Eble. The network helps show where John N. Eble may publish in the future.

Co-authorship network of co-authors of John N. Eble

This figure shows the co-authorship network connecting the top 25 collaborators of John N. Eble. A scholar is included among the top collaborators of John N. Eble based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John N. Eble. John N. Eble is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Al‐Obaidy, Khaleel I., Julia A. Bridge, Liang Cheng, et al.. (2021). EWSR1-PATZ1 fusion renal cell carcinoma: a recurrent gene fusion characterizing thyroid-like follicular renal cell carcinoma. Modern Pathology. 34(10). 1921–1934. 34 indexed citations
2.
Perrino, Carmen M., John N. Eble, Chia‐Sui Kao, et al.. (2019). Plasmacytoid/diffuse urothelial carcinoma: a single-institution immunohistochemical and molecular study of 69 patients. Publisher. 1 indexed citations
3.
Delahunt, Brett, John N. Eble, Lars Egevad, & Hemamali Samaratunga. (2018). Grading of renal cell carcinoma. Histopathology. 74(1). 4–17. 151 indexed citations
4.
Kouba, Erik, Shaoxiong Chen, Sean R. Williamson, et al.. (2016). Solitary fibrous tumour of the genitourinary tract: a clinicopathological study of 11 cases and their association with the NAB2 - STAT6 fusion gene. Journal of Clinical Pathology. 70(6). 508–514. 19 indexed citations
5.
Kouba, Erik, John N. Eble, David J. Grignon, et al.. (2016). High fidelity of driver chromosomal alterations among primary and metastatic renal cell carcinomas: implications for tumor clonal evolution and treatment. Modern Pathology. 29(11). 1347–1357. 7 indexed citations
6.
Martignoni, Guido, Matteo Brunelli, Diego Segala, et al.. (2013). Renal cell carcinoma with smooth muscle stroma lacks chromosome 3p and VHL alterations. Modern Pathology. 27(5). 765–774. 24 indexed citations
7.
Wang, Xiaoyan, Timothy D. Jones, Shaobo Zhang, et al.. (2006). Amplifications of EGFR gene and protein expression of EGFR, Her-2/neu, c-kit, and androgen receptor in phyllodes tumor of the prostate. Modern Pathology. 20(2). 175–182. 20 indexed citations
9.
Jones, Timothy D., Thomas M. Ulbright, John N. Eble, Lee Ann Baldridge, & Liang Cheng. (2004). OCT4 Staining in Testicular Tumors. The American Journal of Surgical Pathology. 28(7). 935–940. 206 indexed citations
11.
Martignoni, Guido, Maurizio Pea, Franco Bonetti, Matteo Brunelli, & John N. Eble. (2002). Oncocytoma-like angiomyolipoma. A clinicopathologic and immunohistochemical study of 2 cases.. Archives of Pathology & Laboratory Medicine. 126(5). 610–612. 43 indexed citations
12.
Pierson, Christopher R., Megan S. Schober, Tracie Wallis, et al.. (2001). Mixed epithelial and stromal tumor of the kidney lacks the genetic alterations of cellular congenital mesoblastic nephroma. Human Pathology. 32(5). 513–520. 44 indexed citations
13.
Kovács, Gyula, Mohammed Akhtar, Bruce Beckwith, et al.. (1997). The Heidelberg classification of renal cell tumours. The Journal of Pathology. 183(2). 131–133. 1041 indexed citations breakdown →
14.
Warschaw, Karen E., John N. Eble, Antoinette F. Hood, Stephen E. Wolverton, & Kevin C. Halling. (1997). The Muir‐Torre syndrome in a black patient with AIDS: histopathology and molecular genetic studies. Journal of Cutaneous Pathology. 24(8). 511–518. 17 indexed citations
15.
Amin, Mahul B., William M. Murphy, Victor E. Reuter, et al.. (1996). A symposium on controversies in the pathology of transitional cell carcinomas of the urinary bladder, Part II.. PubMed. 1. 1–110. 11 indexed citations
16.
Cummings, Oscar W., Thomas M. Ulbright, John N. Eble, & Lawrence M. Roth. (1994). Spermatocytic seminoma: An immunohistochemical study. Human Pathology. 25(1). 54–59. 84 indexed citations
17.
Eble, John N.. (1990). Tumors and tumor-like conditions of the kidneys and ureters. Churchill Livingstone eBooks. 17 indexed citations
18.
Johnson, David A., et al.. (1989). Monoclonal Antibody L/1C2 Reactive with a Human Carcinoma Associated Antigen. Hybridoma. 8(2). 161–173. 3 indexed citations
19.
Lumeng, Lawrence, et al.. (1983). Intrahepatic cholestasis and sicca complex after thiabendazole. Gastroenterology. 85(3). 718–721. 11 indexed citations
20.
Eble, John N.. (1964). A STUDY OF THE MECHANISMS OF THE MODIFYING ACTIONS OF COCAINE, EPHEDRINE AND IMIPRAMINE ON THE CARDIOVASCULAR RESPONSE TO NOREPINEPHRINE AND EPINEPHRINE. Journal of Pharmacology and Experimental Therapeutics. 144(1). 76–82. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026